Erika Vucko
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Erika Vucko has a total of 49 co-authors. Here are the top co-authors by number of shared publications:
- Melissa Lah
Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, USA
3 shared publications - Stephanie Sacharow
Boston Children's Hospital, Boston, MA, USA
3 shared publications Barbara K. Burton
Edwards Family Division of Genetics & Rare Diseases, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL 60611, USA; Department of Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA
2 shared publications- Hans C. Andersson
Hayward Genetics Center, Tulane University School of Medicine, 1430 Tulane Avenue, New Orleans, LA 70112, USA
2 shared publications - Janet A. Thomas
University of Colorado School of Medicine, Aurora, CO, USA
2 shared publications Karen Becker
Edwards Family Division of Genetics & Rare Diseases, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL 60611, USA
2 shared publications
Latest Publications
- Open Access
- 29 May 2026
- Published by Elsevier in Molecular Genetics and Metabolism
- Vol. 148 (4) , 110153
Real-world experience with sepiapterin in phenylketonuria: A single-center retrospective analysis
- 29 May 2026
- Published by Elsevier in Molecular Genetics and Metabolism
- Vol. 148 (4) , 110153
Open AccessReal-world experience with sepiapterin in phenylketonuria: A single-center retrospective analysis
- Open Access
- 8 February 2026
- Published by Elsevier in Molecular Genetics and Metabolism
- Vol. 147 (4) , 109768
Management of pegvaliase-related skin concerns: best practice recommendations using a modified Delphi approach
- 8 February 2026
- Published by Elsevier in Molecular Genetics and Metabolism
- Vol. 147 (4) , 109768
Open AccessManagement of pegvaliase-related skin concerns: best practice recommendations using a modified Delphi approach
- Open Access
- 26 December 2024
- Published by Elsevier in Molecular Genetics and Metabolism Reports
- Vol. 42, 101181
Lessons learned from 5 years of pegvaliase in US clinics: A case series
- 26 December 2024
- Published by Elsevier in Molecular Genetics and Metabolism Reports
- Vol. 42, 101181
Open AccessLessons learned from 5 years of pegvaliase in US clinics: A case series
- Open Access
- 25 June 2024
- Published by Elsevier in Molecular Genetics and Metabolism Reports
- Vol. 39 (Suppl 1) , 101108
Management of a urea cycle disorder in the setting of socioeconomic and language barriers
- 25 June 2024
- Published by Elsevier in Molecular Genetics and Metabolism Reports
- Vol. 39 (Suppl 1) , 101108
Open AccessManagement of a urea cycle disorder in the setting of socioeconomic and language barriers
- Open Access
- 1 August 2022
- Published by Elsevier in Molecular Genetics and Metabolism Reports
- Vol. 32, 100905
Pegvaliase dose escalation to 80 mg daily may lead to efficacy in patients who do not exhibit an optimal response at lower doses
- 1 August 2022
- Published by Elsevier in Molecular Genetics and Metabolism Reports
- Vol. 32, 100905
Open AccessPegvaliase dose escalation to 80 mg daily may lead to efficacy in patients who do not exhibit an optimal response at lower doses
- Open Access
- 14 August 2021
- Published by Elsevier in Molecular Genetics and Metabolism Reports
- Vol. 28, 100790
Use of pegvaliase in the management of phenylketonuria: Case series of early experience in US clinics
- 14 August 2021
- Published by Elsevier in Molecular Genetics and Metabolism Reports
- Vol. 28, 100790
Open AccessUse of pegvaliase in the management of phenylketonuria: Case series of early experience in US clinics
- 1 June 2018
- Published by Wolters Kluwer Health in AJN, American Journal of Nursing
- Vol. 118 (6) , 36-42
CE: Understanding the Nurse's Role in Managing Gaucher Disease
Lysosomal storage disorders (LSDs) are a group of inherited metabolic conditions, the overall incidence of which is estimated to range from one in 5,000 to one in 7,000 live births. Gaucher disease, the most common LSD, is of autosomal recessive inheritance. It results from a deficiency of acid β-glucocerebrosidase and can affect the spleen, liver, bone, bone marrow, and central nervous system. Gaucher disease is clinically classified into one of three phenotypes, depending on the absence or presence of neurodegenerative disease and the rate of disease progression. Although there is no cure for Gaucher disease, it may be treated with enzyme replacement and substrate reduction therapy. With the development of enzyme testing through dried blood spots, Gaucher disease may now be detected at birth through newborn screening. The purpose of this article is to review the epidemiology and pathophysiology of Gaucher disease, update nurses on advances in newborn screening, diagnosis, and management of this genetic disorder, and highlight the role of nurses in the diagnosis and care of patients with Gaucher disease.
- 1 June 2018
- Published by Wolters Kluwer Health in AJN, American Journal of Nursing
- Vol. 118 (6) , 36-42
CE: Understanding the Nurse's Role in Managing Gaucher Disease
Lysosomal storage disorders (LSDs) are a group of inherited metabolic conditions, the overall incidence of which is estimated to range from one in 5,000 to one in 7,000 live births. Gaucher disease, the most common LSD, is of autosomal recessive inheritance. It results from a deficiency of acid β-glucocerebrosidase and can affect the spleen, liver, bone, bone marrow, and central nervous system. Gaucher disease is clinically classified into one of three phenotypes, depending on the absence or presence of neurodegenerative disease and the rate of disease progression. Although there is no cure for Gaucher disease, it may be treated with enzyme replacement and substrate reduction therapy. With the development of enzyme testing through dried blood spots, Gaucher disease may now be detected at birth through newborn screening. The purpose of this article is to review the epidemiology and pathophysiology of Gaucher disease, update nurses on advances in newborn screening, diagnosis, and management of this genetic disorder, and highlight the role of nurses in the diagnosis and care of patients with Gaucher disease.